These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 29331417)
1. Down-regulation of RIP3 potentiates cisplatin chemoresistance by triggering HSP90-ERK pathway mediated DNA repair in esophageal squamous cell carcinoma. Sun Y; Zhai L; Ma S; Zhang C; Zhao L; Li N; Xu Y; Zhang T; Guo Z; Zhang H; Xu P; Zhao X Cancer Lett; 2018 Apr; 418():97-108. PubMed ID: 29331417 [TBL] [Abstract][Full Text] [Related]
2. PGK1 facilities cisplatin chemoresistance by triggering HSP90/ERK pathway mediated DNA repair and methylation in endometrial endometrioid adenocarcinoma. Zhou JW; Tang JJ; Sun W; Wang H Mol Med; 2019 Mar; 25(1):11. PubMed ID: 30925862 [TBL] [Abstract][Full Text] [Related]
3. A cytosolic heat shock protein 90 and cochaperone CDC37 complex is required for RIP3 activation during necroptosis. Li D; Xu T; Cao Y; Wang H; Li L; Chen S; Wang X; Shen Z Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5017-22. PubMed ID: 25852146 [TBL] [Abstract][Full Text] [Related]
4. Receptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cells. Xu Y; Lin Z; Zhao N; Zhou L; Liu F; Cichacz Z; Zhang L; Zhan Q; Zhao X PLoS One; 2014; 9(6):e100127. PubMed ID: 24959694 [TBL] [Abstract][Full Text] [Related]
5. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma. Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477 [TBL] [Abstract][Full Text] [Related]
6. The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma. Shi Q; Shen LY; Dong B; Fu H; Kang XZ; Yang YB; Dai L; Yan WP; Xiong HC; Liang Z; Chen KN Cancer Lett; 2018 Sep; 432():56-68. PubMed ID: 29890208 [TBL] [Abstract][Full Text] [Related]
7. Ablative Hypofractionated Radiation Therapy Enhances Non-Small Cell Lung Cancer Cell Killing via Preferential Stimulation of Necroptosis In Vitro and In Vivo. Wang HH; Wu ZQ; Qian D; Zaorsky NG; Qiu MH; Cheng JJ; Jiang C; Wang J; Zeng XL; Liu CL; Tian LJ; Ying GG; Meng MB; Hao XS; Yuan ZY Int J Radiat Oncol Biol Phys; 2018 May; 101(1):49-62. PubMed ID: 29619976 [TBL] [Abstract][Full Text] [Related]
8. ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts. Washington MN; Suh G; Orozco AF; Sutton MN; Yang H; Wang Y; Mao W; Millward S; Ornelas A; Atkinson N; Liao W; Bast RC; Lu Z Cell Death Dis; 2015 Aug; 6(8):e1836. PubMed ID: 26247722 [TBL] [Abstract][Full Text] [Related]
9. RIPK1 contributes to cisplatin-induced apoptosis of esophageal squamous cell carcinoma cells via activation of JNK pathway. Zhang Y; Du J; Duan X; Peng W; Lv L; Chen Z; Zhang Y Life Sci; 2021 Mar; 269():119064. PubMed ID: 33460665 [TBL] [Abstract][Full Text] [Related]
10. Entinostat reverses cisplatin resistance in esophageal squamous cell carcinoma via down-regulation of multidrug resistance gene 1. Huang XP; Li X; Situ MY; Huang LY; Wang JY; He TC; Yan QH; Xie XY; Zhang YJ; Gao YH; Li YH; Rong TH; Wang MR; Cai QQ; Fu JH Cancer Lett; 2018 Feb; 414():294-300. PubMed ID: 29107111 [TBL] [Abstract][Full Text] [Related]
11. 3-O-(Z)-coumaroyloleanolic acid overcomes Cks1b-induced chemoresistance in lung cancer by inhibiting Hsp90 and MEK pathways. Wang H; Sun M; Guo J; Ma L; Jiang H; Gu L; Wen H; Liao S; Chen J; Zeng B; Li Y; Li Y; Yu X; Feng Y; Zhou Y Biochem Pharmacol; 2017 Jul; 135():35-49. PubMed ID: 28288818 [TBL] [Abstract][Full Text] [Related]
12. MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma. Kong LR; Chua KN; Sim WJ; Ng HC; Bi C; Ho J; Nga ME; Pang YH; Ong WR; Soo RA; Huynh H; Chng WJ; Thiery JP; Goh BC Mol Cancer Ther; 2015 Jul; 14(7):1750-60. PubMed ID: 25939760 [TBL] [Abstract][Full Text] [Related]
13. Phospho-ΔNp63α-responsive microRNAs contribute to the regulation of necroptosis in squamous cell carcinoma upon cisplatin exposure. Ratovitski EA FEBS Lett; 2015 May; 589(12):1352-8. PubMed ID: 25910754 [TBL] [Abstract][Full Text] [Related]
14. Natural Product Kongensin A is a Non-Canonical HSP90 Inhibitor that Blocks RIP3-dependent Necroptosis. Li D; Li C; Li L; Chen S; Wang L; Li Q; Wang X; Lei X; Shen Z Cell Chem Biol; 2016 Feb; 23(2):257-266. PubMed ID: 27028885 [TBL] [Abstract][Full Text] [Related]
15. Distinctive roles of receptor-interacting protein kinases 1 and 3 in caspase-independent cell death of L929. Park SY; Shim JH; Cho YS Cell Biochem Funct; 2014 Jan; 32(1):62-9. PubMed ID: 23584955 [TBL] [Abstract][Full Text] [Related]
16. 14-3-3σ confers cisplatin resistance in esophageal squamous cell carcinoma cells via regulating DNA repair molecules. Lai KK; Chan KT; Choi MY; Wang HK; Fung EY; Lam HY; Tan W; Tung LN; Tong DK; Sun RW; Lee NP; Law S Tumour Biol; 2016 Feb; 37(2):2127-36. PubMed ID: 26346170 [TBL] [Abstract][Full Text] [Related]
17. Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells. To KK; Yu L; Liu S; Fu J; Cho CH Mol Carcinog; 2012 Jun; 51(6):449-64. PubMed ID: 21678497 [TBL] [Abstract][Full Text] [Related]
18. SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer. Huang Z; Li H; Huang Q; Chen D; Han J; Wang L; Pan C; Chen W; House MG; Nephew KP; Guo Z Mol Carcinog; 2014 Oct; 53(10):777-86. PubMed ID: 23661500 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma. Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231 [TBL] [Abstract][Full Text] [Related]
20. Heat shock protein 90 (HSP90) is overexpressed in p16-negative oropharyngeal squamous cell carcinoma, and its inhibition in vitro potentiates the effects of chemoradiation. Patel K; Wen J; Magliocca K; Muller S; Liu Y; Chen ZG; Saba N; Diaz R Cancer Chemother Pharmacol; 2014 Nov; 74(5):1015-22. PubMed ID: 25205430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]